Report: Opioids settlement won’t fix areas hardest hit

A new analysis finds that money from a tentative settlement with OxyContin maker Purdue Pharma will be “no more than a stopgap” for state and local governments struggling to combat the opioid epidemic. Purdue became the first company being sued over the toll of opioids to reach a tentative nationwide settlement. If approved, it could be worth up to $12 […]

Read more